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Abstract
BACKGROUND: Agreement between gated myocardial perfusion SPECT (GSPECT) and echocardiography (ECHO) in the 
calculation of left ventricular end-diastolic volume (EDV), end-systolic volume (ESV) and LVEF was assessed. Effect of perfusion 
defect and small hearts on this agreement was obtained. Because ECHO is a routine and widely used noninvasive modality 
for this purpose, we chose this technique for comparison with GSPECT.
MATERIAL AND METHODS: In a prospective study, 50 consecutive patients (age = 59.7 ± 10.64 years) underwent rest Tc99m-ses-
tamibi GSPECT and 2-D ECHO. The LVEF, EDV and ESV were calculated using QGS (Quantitative Gated SPECT) software.
RESULTS: Fourteen (28%) patients had perfusion defect in rest phase tomograms, while 36 (72%) had no perfusion defect. 
There was a significant correlation between two modalities in calculation of EDV, ESV and LVEF (all: p < 0.001, Pearson’s cor-
relation coefficients: r = 0.764, 0.831 and 0.813, respectively). A good correlation was noticed even in small hearts or in patients 
with or without previous myocardial infarction. There was a significant difference between GSPECT and ECHO in patients with 
no perfusion defect as well as in patients with small heart (ESV < 25 ml). On the other hand, no remarkable difference was 
noticed between two techniques in the presence of perfusion defect or in patients with ESV ≥ 25 ml.
CONCLUSION: There was a good agreement between EDV, ESV and LVEF derived from GSPECT and ECHO. There was a sig-
nificant difference between two modalities in small hearts and in patients without perfusion defect, although in larger ventricles 
or in the presence of myocardial infarction no remarkable difference between two modalities was noticed. 
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Background
Left ventricular function indicators including left ventricular 
volumes (LVVs) and ejection fraction (LVEF) are powerful and reli-
able in terms of their diagnostic and prognostic value, especially 
in coronary artery disease [1–4]. Nowadays, several modalities in-
cluding echocardiography (ECHO), gated myocardial perfusion 
single photon emission tomography (GSPECT) , cardiac magnetic 
resonance imaging (cMRI), and radionuclide ventriculography 
(RNV) are available for the assessment of LVVs and LVEF [2, 
5, 6]. Consequently, physicians would be faced with results of 
various imaging techniques during follow-up periods. Therefore, it 
is necessary for a cardiologist to be familiar with agreement between 
these modalities [2]. In clinical practice, this task is most commonly 
performed using 2-D echocardiography and more or less GSPECT 
[7]. GSPECT offers quantification of three-dimensional assessment 
of regional left ventricular function and simultaneous evaluation of 
both LV function and perfusion in a single study [4, 8]. According 
to previously published studies, there seems to be good agree-
ment between different noninvasive methods for calculation of LV 
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functional indices [9]. However, concerns have been raised about 
the different findings in particular situations, such as in the pres-
ence of perfusion defects [8] or in patients with small heart [9–11]. 
In this study, we tried to assess the correlation between gated 
SPECT and ECHO in the evaluation of left ventricular end-diastolic 
volume (EDV), end-systolic volume (ESV) and LVEF. Effect of 
perfusion defect and small hearts on this agreement between the 
results obtained. Because ECHO is a routine and widely used 




In a prospective study, 50 consecutive patients (22 males and 28 
females) with known or suspected coronary artery disease, referred 
for routine GSPECT underwent gated myocardial perfusion SPECT 
and two-dimensional echocardiogram within a 7-d period. There 
were no cardiac events between two studies. The patients’ mean age 
was 59.70 ± 10.64 years (range 37–85 years). The local ethics commit-
tee approved the study and all patients gave their informed consent.
Gated SPECT
All patients underwent two-day stress-rest Tc99m-MIBI (meth-
oxyisobutyl-isonitrile) gated SPECT which rest images were used 
for this study. Rest GSPECT acquisition was started after 90 minu-
tes of the intravenous injection of 740-925 MBq Tc99m-MIBI. Data 
acquisition was performed with a dual-head SPECT system with 
the detectors oriented at 90 degrees (Dual-Head Variable-Angle 
E.CAM; Siemens) equipped with a low-energy-high resolution 
collimator. A 20% window with 140 keV energy peak was used. 
A total of 32 projections (step-and-shoot mode, 25 s per view) 
were obtained over a 180° arc commencing from the right anterior 
oblique to left posterior oblique view. We used a zoom factor of 
1.45 and gating at 8 frames per cardiac cycle. The images were 
stored in a 64 × 64 matrix in the computer and reconstructed by 
filtered back-projection using a Butterworth filter (cut-off value 
was 0.35 cycle/cm for gated data but 0.55 cycle/cm for ungated 
data, order = 5). No attenuation or scatter correction was applied. 
All reconstructed tomographic images were interpreted by consen-
sus of 2 experienced physicians. Rest tomograms images were 
evaluated visually with respect to presence of defect. Based on 
17-segment model and 5-point scale system (0 — normal perfu-
sion; 1 — mildly reduced uptake; 2 — moderately reduced uptake; 
3 — severely reduced uptake; and 4 — absent uptake) was used 
for semi-quantitative assessment of rest myocardial perfusion 
tomograms (including six basal, six mid-ventricular and four apical 
segments in short axis slices and one additional mid-ventricular api-
cal slice in the vertical long axis) [4]. The summed rest score (SRS) 
was calculated. The LVEF, EDV and ESV were calculated using pre-
viously validated and commercially available automated software: 
QGS (Quantitative Gated SPECT) from the rest GSPECT images. 
Echocardiography
The two-dimensional echocardiograms according to the criteria 
of the American Society of Echocardiography were acquired at 
rest with standard short axis, apical and parasternal views using 
a GE Vivid 3 ultrasound system (GE Vingmed, Horten, Norway) 
and a 3MHZ probe by one experienced cardiologist blind to the 
results of the GSPECT study. The measurements were made by 
tracing the endocardium in end-systolic and diastolic phases using 
the Biplane Simpson’s rule.
Statistical analysis
Numerical values of LVEF, EDV and ESV derived from GSPECT 
and ECHO were compared. Continuous data were expressed 
as means ± SD. To determine agreement between two modalities, 
Pearson’s correlation coefficient was used. Paired sample t-test 
was used for the assessment of differences between two methods. 
Small ventricles were defined as end-systolic volumes < 25 ml 
as measured with QGS [10, 11]. Differences in average EDV, ESV 
and LVEF between echocardiography and GSPECT in patients with 
small heart or with normal size heart as well as in patient with or 
without perfusion defect were tested with independent sample 
t-test. P < 0.05 was considered statistically significant. All statisti-
cal analyses were performed with SPSS for Windows (SPSS 20).
Results
The clinical characteristics of all patients are described in Table 1. 
The SRS was 4.62 ± 7.80 (0–28). Fourteen (28%) patients had 
perfusion defect in rest phase tomograms, while 36 (72%) had no 
perfusion defect. Table 2 shows EDV, ESV and LVEF calculated 
with GSPECT and ECHO in all patients as well as in patients with 
and without perfusion defect. There was a significant correlation 
between two modalities in calculation of EDV, ESV and LVEF (all: 
p < 0.001) (Figure 1). Pearson’s correlation coefficients for EDV, ESV 
and LVEF were r = 0.764, 0.831 and 0.813, respectively (p < 0.001). 
There was also a significant correlation between two modalities in 
patients both with and without perfusion defect. To determine the 
effect of severity of perfusion defect, patients were categorized 
based on their SRS: mild defect — SRS ≤ 3, significant defect 
— SRS>3 (Table 3). The patients with ESV < 25ml on GSPECT 
were considered as patients with small heart [10, 11]. GSPECT 
and ECHO findings based on ESV < 25 ml and ESV ≥ 25 ml are 
shown in Table 4. 
Discussion
LV functional indices have major clinical diagnostic and prog-
nostic importance in the management of patients with known or 
Table 1. Patient characteristics
Variable n = 50
Age (mean ± SD) 59.70 ± 10.64
Sex
 Female 28 (56%)
 Male 22 (44%)
History
 Diabetes mellitus 18 (36%)
 Hypertension 27 (54%)
 Hyperlipidemia 16 (32%)
 Smoking 10 (20%)
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Table 2. Calculated EDV, ESV and LVEF using rest gated myocardial perfusion SPECT (GSPECT) and echocardiography (ECHO) in all patients as 
well as in two subgroups: with and without perfusion defect
Variable Patients GSPECT ECHO p value
EDV No perfusion defect  51.42 ± 19.90  72.58 ± 21.01 < 0.001
With perfusion defect 144.93 ± 59.99 125.21 ± 49.10 0.16
All  77.60 ± 55.10  87.32 ± 39.05 0.068
ESV No perfusion defect  16.61 ± 19.69  33.83 ± 10.87 < 0.001
With perfusion defect  98.43 ± 63.05  94.29 ± 37.92 0.74
All  39.52 ± 52.04  50.76 ± 34.89 0.01
LVEF No perfusion defect  73.58 ± 20.26 58.06 ± 8.57 < 0.001
With Perfusion defect  33.21 ± 18.36  30.93 ± 14.30 0.33
All  62.28 ± 26.80  50.46 ± 16.06 < 0.001
Table 3. Calculated EDV, ESV and LVEF using rest gated myocardial perfusion SPECT (GSPECT) and echocardiography (ECHO) based on 
summed rest score
Variable Patients GSPECT ECHO p value
EDV SRS ≤ 3  56.68 ± 37.43  74.29 ± 24.74 0.001
SRS > 3 143.83 ± 50.15 128.58 ± 47.85 0.30
ESV SRS ≤ 3  22.21 ± 38.56  36.03 ± 18.70 0.002
SRS > 3  94.33 ± 52.46  97.42 ± 33.51 0.80
LVEF SRS ≤ 3  71.47 ± 22.37  56.97 ± 10.56 < 0.001
SRS > 3  33.17 ± 17.26  29.83 ± 12.78 0.20
Table 4. Calculated EDV, ESV and LVEF using rest gated myocardial perfusion SPECT (GSPECT) and echocardiography (ECHO) based on ESV 
derived from GSPECT
Variable Patients (n) GSPECT ECHO p value
EDV Small heart (32)  48.00 ± 19.55  66.53 ± 21.03 0.002
No small heart (18) 130.22 ± 58.94 124.28 ± 36.45 0.55
ESV Small heart (32)  9.56 ± 6.70  33.25 ± 15.27 < 0.001
No small heart (18)  92.78 ± 55.07  81.89 ± 38.49 0.23
LVEF Small heart (32)  79.09 ± 15.36 59.00 ± 9.35 < 0.001
No small heart (18)  32.39 ± 12.69  35.28 ± 14.25 0.32
Figure 1. Scatter plot and linear correlation between echocardiography and gated myocardial perfusion SPECT (GSPECT) in caculation of EDV, 
ESV and LVEF
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suspected CAD [12]. Previous studies have compared the accuracy 
of GSPECT as compared to other imaging techniques such as 2D 
and 3D ECHO, contrast angiography, cMRI, equilibrium radio-
nuclide angiography (ERNA) and computed tomography [5, 9]. 
In this study, we examined the correlation between automatic 
quantitative gated SPECT and ECHO in the evaluation of LVVs and 
LVEF as well as effect of perfusion defect and small hearts on 
this agreement between the results obtained. Our study showed 
a good correlation between GSPECT and ECHO for the deter-
mination of EDV, ESV and LVEF, even in patients with or without 
myocardial perfusion defects. This correlation was also noticed in 
patient with small heart or with normal size heart. However when 
we tested the differences between GSPECT and ECHO, we saw 
that there was a difference between indices calculated by ECHO 
and GSPECT in patients with small heart, and in patients with no 
perfusion defect or in patients with low SRS. On the other hand, 
in the presence of perfusion defect, in higher SRS scores and in 
patients with larger ventricle (ESV ≥ 25 ml), no remarkable difference 
was noticed between two modalities. 
Similarly to our study, previous studies that compared GSPECT 
and ECHO, reported good agreement between LVEF, EDV and ESV 
values [2, 9, 12–17]. Zanger et al. [18] reported a good agreement 
between ECHO and GSPECT for determination of LVEF and LVVs. 
Demir et al. reported strong correlation between these two modali-
ties for the calculation of LVEF, EDV and ESV (r = 0.91, r = 0.81, 
r = 0.71, respectively) [2]. Fleming et al. reported good correla-
tion in patients with single-vessel disease (r = 0.76), 2- (r = 0.68) 
and 3-vessel disease (r = 0.68), respectively [13]. This correlation 
between ECHO and GSPECT was also reported in patients with 
dilated cardiomyopathy [14]. 
In all patients, calculated ESV (p = 0.01) and EDV (p = 0.06; 
close to being statistically significant) using GSPECT were less than 
ECHO results, while LVEF (p = 0.001) was significantly higher in 
GSPECT. However, there was a significant increase in these dif-
ferences in patients with small heart as well as in patients with 
no perfusion defect. On the other hand, in patients with perfusion 
defect as well as in patients with ESV ≥ 25 ml no remarkable dif-
ference was noticed between two techniques. For the description 
of this phenomenon in patients with small heart, several physical 
factors may contribute in GSPECT such as photon scatter, poor 
spatial resolution, and partial volume effect. Indeed, due to the 
limited spatial resolution of gamma cameras, the opposite endo-
cardial edges of the left ventricle overlap, so that the ventricular 
cavity may become almost virtual, especially at end-systole. 
Increased counts of scintigraphic images at end-systole com-
plicated the identification of LV endocardial borders. The root of 
this problem may be that counts from close myocardial walls spill 
into opposite walls, thereby distorting count profiles and causing 
their local maxima to be misregistered toward the center of the left 
ventricular cavity. Because the effect would be most pronounced 
at end-systole, the calculated LVEF is artifactually high [10, 11]. 
In patients with small ventricles, the LVEF may be overestimated 
because of underestimation of volumes, particularly in end-systole 
[10–12]. Typically, these patients have a normal heart but their LVEF 
may be falsely elevated. As we previously showed, in our country 
most people with normal myocardial perfusion and low probability 
of CAD have small heart (123/144: 85.4% had small heart with ESV 
less than 25 ml) [11]. But when the heart is larger (for example in 
patients with coronary artery disease in the presence of perfusion 
defect), the mentioned above effect would be minimized. As we 
can see in this study, there is no remarkable difference between 
ECHO and GSPECT in patients with ESV > 25 ml as well as in 
patients with myocardial perfusion defect. 
Few papers have focused on the patients with perfusion de-
fect. Chua et al. [8] reported a good correlation between gated 
SPECT and ERNA for the determination of LVEF, even in the pres-
ence of large perfusion defects. In the presence of transmural 
myocardial infarction, GSPECT software may impair accurate 
assessment of endocardial borders. In spite of this, it has been 
validated against other modalities (cMRI and first pass ERNA) 
[8]. Also Iskandarian et al. [19] and Tadamura [20] found a good 
correlation between gated SPECT and cMRI in patients with myo-
cardial infarction. 
Because the differences between different modalities are 
well-recognized, small and predictable differences should not 
detract from the clinical usefulness of each method.
Conclusion
We found good correlations and agreements between EDV, ESV 
and LVEF derived from GSPECT and ECHO. This good correlation 
was noticed even in small hearts or in patients with or without previ-
ous myocardial infarction. On the other hand, there was a significant 
difference between two modalities in patients with small hearts and 
in patients without perfusion defect. However in patients with larger 
ventricles including patients with perfusion defect, no remarkable 
difference between two modalities were noticed. 
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